Navigation Links
YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets,Primary Endpoint in Patients with Post-Surgical Pain

re pain, including cancer pain.

This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that nimotuzumab will continue to demonstrate a competitive safety profile in ongoing and future clinical trials; and that YM and its various partners will complete their respective clinical trials within the timelines communicated in this release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: Enquiries: Thomas Fechtner, the Trout Group LLC, Tel. (212)477-9007 x31, Fax (212) 460-9028, Email: ; JamesSmith, the Equicom Group Inc., Tel. (416) 815-0700 x 229, Fax (416)815-0080, Email: tfechtner@troutgroup.com jsmith@equicomgroup.com

Ticker Symbol: (Toronto:YM.),(AMEX:YMI)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
3. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
4. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
5. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
6. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
7. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
8. IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
(Date:8/22/2014)... 22, 2014  As the Medical Affairs, role has ... in this area are exploring methods to develop strong ... Affairs Consortium at Best Practices, LLC is designed to ... about the key challenges they face. The consortium will ... three virtual roundtable discussions where leaders discuss key findings ...
(Date:8/22/2014)... 22, 2014  Dr. Mark Rasak , MD ... Lifetime Achievement Award in the field of Medicine as ... Clinical Associates. Dr. Rasak has over 15 ... aspects of the business; overseeing the daily operations; interventional ... intervention. In addition, he is an honored Fellow of ...
(Date:8/22/2014)...   Zacks Equity Research highlights Epizyme (Nasdaq: EPZM ... Panera (Nasdaq: PNRA - Free Report ) as the Bear ... Amicus Therapeutics (Nasdaq: FOLD - Free Report ), Sanofi (NYSE: ... - Free Report ). Here is a synopsis of ... : The biotech bull market is far from ...
Breaking Medicine Technology:Best Practices' Medical Affairs Consortium Survey Has Achieved Strong Participation 2Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 4Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 5Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 6
... 2011 The U.S. Food and Drug Administration today ... sting by Centruroides scorpions in the United ... Venomous scorpions in the U.S. are mostly ... infants and children, and can cause shortness of breath, ...
... CPHD ) today announced that its executives will ... to participate via webcast. Canaccord Genuity Growth Conference, ... Time Wedbush 2011 Life Sciences Conference, New York, ... Baird 2011 Health Care Conference, New York, NY ...
Cached Medicine Technology:FDA Approves the First Specific Treatment for Scorpion Stings 2Cepheid to Webcast Upcoming Financial Presentations 2
(Date:8/23/2014)... (PRWEB) August 23, 2014 Young adults in Athens, ... doing drugs should pick up the phone and call the new ... teen drug addict . , Troubled Teen Athens is a ... ready to finally take the necessary steps to end substance abuse ... are quick to go to friends or peers when really they ...
(Date:8/23/2014)... is almost over and before we know it schools and ... supplies and a new wardrobe might take precedence over the ... spend some time brushing up on bed bug prevention tips. ... populated places,” said Randy Rupert, Bed Bug Team Lead at ... bed bugs to take up residence.” , An already notorious ...
(Date:8/22/2014)... 23, 2014 Recently, Skmen.com, an experienced ... of 2014 bohemian dresses in its online store. Moreover, ... prices, up to 28% off. All the international clients ... August 31, 2014. , The company’s professional online ... to show worldwide customers more the latest information about ...
(Date:8/22/2014)... Recently, UWDress.com, a leading online supplier of ... new range of empire bridesmaid dresses to its ... a summer promotion for these high quality items. All of ... to 75 percent off. , The company’s new items ... efficient assistance on its website. It is true that all ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Millennium Treatment Group ... resulting in a high level of drug use among teenagers. ... fight against drug addiction and work to minimize drug abuse. ... of alcohol and drug addiction in history. According to the ... estimated 23.9 million Americans aged 12 or older—or 9.2 percent ...
Breaking Medicine News(10 mins):Health News:Teenagers in Athens, GA are Locating Addiction Recovery Thanks to New Helpline 2Health News:Expert Advice for a Bed Bug-Free School Year 2Health News:Cheap Bohemian Dresses Unveiled by Experienced Supplier Skmen.com 2Health News:Discounted Empire Bridesmaid Dresses Online At UWDress.com 2Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2
... ,Child-Friendly Spaces, to help children cope with ... disaster - Children have ... ... YANGON, Myanmar, May 14 World Vision is addressing the,emotional and physical needs of children ...
... AMDL, Inc. (Amex:,ADL), headquartered in Tustin, ... China, is a vertically integrated specialty,pharmaceutical company. ... AMDL engages in the research, development, manufacture, ... products currently in China. The Company today ...
... St. Louis, PLEASANT GROVE, Utah, May 14 ... pleased to,announce the inclusion of Myo-Med in the new ... Meeting in St. Louis, MO,June 17-21. The company launched ... a favorite with top athletes. Among those endorsing,Myo-Med are ...
... Pharmacyclics, Inc.,(Nasdaq: PCYC ) announced today that ... the Securities and Exchange,Commission (the "Commission"), as required ... tender offer (the "Offer") by RWD Acquisition I,LLC ... shares of the common,stock of Pharmacyclics, Inc. (the ...
... NARAL Pro-Choice,America endorsed Senator Barack Obama for President., ... Pro-Choice America, based in,Washington D.C., and without the ... NARAL Pro-Choice Pennsylvania will not be issuing ... that this endorsement in,the Democratic primary is premature. ...
... Inc.,(Nasdaq: CPTS ) developer of the Essure(R) ... method available, today reported,that Medi-Cal, California,s state fee-for-service ... or disabled women in California,now have a safe ... not require the general anesthesia, incisions or long ...
Cached Medicine News:Health News:Myanmar: Half a Million Children Affected by Cyclone, Aid Agency Warns 2Health News:Myanmar: Half a Million Children Affected by Cyclone, Aid Agency Warns 3Health News:AMDL Subsidiary Donates Pharmaceuticals in China Earthquake Relief Effort 2Health News:Toxin-Free Pain Cream to Make First Appearance at Athletic Trainer Event 2Health News:Pharmacyclics Files Schedule 14D-9 Statement with Securities and Exchange Commission 2Health News:Essure Procedure Now Covered by Medicaid in California 2Health News:Essure Procedure Now Covered by Medicaid in California 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: